resveratrol/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Increases malondialdehyde (circulating)
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“After 12 weeks, MDA levels increased significantly in both groups, with a larger rise in the RES group, resulting in significantly higher MDA levels in the RES group compared to the control at the end of the study.”
Quoted verbatim from Does Resveratrol Impact Oxidative Stress Markers in Patients with Head and Neck Cancer Receiving Home Enteral Nutrition?. - Study
- RCT
- Participants
- 40
- Duration
- 3 months
- Dose
- 400 mg/day liposomal resveratrol via enteral access, in two doses
- Population
- adults with head and neck cancer on home enteral nutrition; open-label, resveratrol plus HEN versus HEN alone
Does Resveratrol Impact Oxidative Stress Markers in Patients with Head and Neck Cancer Receiving Home Enteral Nutrition?2025PMID:39940362Permalink
Keep reading
- Everything the graph holds on resveratrol
- Every compound studied against Malondialdehyde (circulating)
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M0XYT2GET6YKFB3BSMH73XTG